Publication | Closed Access

Initial Risk Assessment as part of the Quality by Design in peptide drug containing formulation development

Medicinal ChemistryPreclinical Drug EvaluationDrug DesignMedicineNatural SciencesPeptide DrugPeptide EngineeringPeptide TherapeuticFormulation DevelopmentPeptide TherapeuticsInitial Risk AssessmentPharmacologyDrug DiscoveryPharmaceutical Research